|
|
Article: Loteprednol, azelastine provide potent arsenal for acute, chronic allergic conjunctivitis
- Article from:
- Ophthalmology Times
- Article date:
- April 15, 2002
- Author:
CopyrightCopyright Advanstar Communications, Inc. Apr 15, 2002. Provided by ProQuest LLC. (Hide copyright information)
|
Managing symptoms
Longer-term use proving safe, effective for patients with both seasonal and perennial allergies
Loteprednol etabonate 0.2% (Alrex, Bausch & Lomb) and azelastine hydrochloride 0.05% (Optivar, Muro) are both valuable options for the management of seasonal and perennial allergic conjunctivitis, said Charles Slonim, MD.
Loteprednol offers the unsurpassed efficacy of a corticosteroid for suppressing ocular inflammation and so might be considered the treatment of choice for the acute management of moderate to severe allergic conjunctivitis and even of milder disease that is highly symptomatic, he said.
A retrospective safety analysis under way aims to corroborate ...